Estimation of Dietary Fat Intake of Belgian Pregnant Women
de Vriese S.R.a · de Henauw S.b · de Backer G.b · Dhont M.c · Christophe A.B.a
Comparison of Two Methods
aDepartment of Internal Medicine, Section of Endocrinology and Metabolic Diseases – Division of Nutrition, bDepartment of Public Health, and cDepartment of Gynaecology, Ghent University Hospital, Ghent, Belgium
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Aim: To evaluate the validity and usefulness of a food frequency questionnaire (FFQ) which was designed to evaluate individual fat consumption for a Dutch population relative to 7-day estimated records (7d ER). The FFQ has been validated previously and was adapted to the Belgian situation. Methods: Longitudinal study in 26 healthy pregnant women; FFQ and 7d ER were obtained during the 1st and 3rd trimesters. Results: FFQ was validated with 7d ER. Fat and fatty acid intake estimated by the FFQ did not differ significantly (p < 0.01) from data obtained by the 7d ER except for 18:2n–6. Pearson correlation coefficient between the 2 methods ranged from 0.62 to 0.68. On average, 47% of the women were classified in the same quartile with the 2 methods and less than 2% in the opposite quartile. Total fat intake, calculated from FFQ, was on average 87.9 (SD 18.1) g/day. The mean intake of linoleic acid was 13.3 (SD 5.4) g/day and of α-linolenic acid was 1.4 (SD 0.5) g/day. The dietary intake of the saturated, monounsaturated and polyunsaturated fatty acids was respectively 34.7 (SD 10.0) g/day, 29.6 (SD 8.1) g/day and 15.7 (SD 5.9) g/day. Conclusion: The FFQ gives similar results for fat intake as the 7d ER and is thus considered an appropriate method for classifying individuals to the right part of the distribution of dietary fat intake.
© 2001 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.